A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $18.0, a ...
HC Wainwright Reiterates “Buy” Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)
Vanda Pharmaceuticals (NASDAQ:VNDA – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a research note issued to investors on Tuesday,Benzinga reports. They currently have a ...
US retail investors dive into tech stocks in response to DeepSeek selloff
Individual investors responded to the market selloff earlier this week triggered by concerns regarding a Chinese artificial ...
Nasdaq9d
A Glimpse Into The Expert Outlook On Vanda Pharma Through 4 Analysts
With an impressive ROE of -0.98%, the company showcases effective utilization of equity capital. Return on Assets (ROA): Vanda Pharma's ROA surpasses industry standards, highlighting the company's ...
As DeepSeek panic set in, retail investors were buying the dip
"Retail investors have (so far) responded to the DeepSeek-induced equity sell-off by doing what they do best: buying the dip." That's from Vanda Research's new bulletin analyzing the trading of ...
Tech investors are aggressively buying the dip: Morning Brief
Tech stocks have been volatile — especially Nvidia, which fell 17% after DeepSeek spooked investors. But many of them ...
Tech shares struggle to regain footing after epic DeepSeek mauling
By Ankur Banerjee, Amanda Cooper and Medha Singh LONDON/SINGAPORE (Reuters) - A nascent recovery in technology shares ...
US tech shares recover some losses from steep DeepSeek selloff
By Sinéad Carew, Medha Singh, Amanda Cooper NEW YORK/BENGALURU/LONDON (Reuters) -Technology shares on Tuesday regained some ...
Wall St. indexes end up as investors weigh earnings
STORY: U.S. stocks ended higher on Thursday as investors digested a stack of key earnings reports, including from megacap ...